Epstein Secrets

AL EMAIL] - FBI Public Affairs News Briefing Friday, October 09, 2020 To: [email protected] Sent: October 9, 2020 6:29 AM (UTC-04:00) Mobile version and searchable archives available at fbi.bulletinintellicience.com. TO : THE DIRECTOR AND SENIOR STAFF DATE : FRIDAY, OCTOBER 9 , 2

er, joined him in the Oval Office today, according to a senior White House official. All they say wearing full PPE." The AE (10/8, Madhani, Colvin, Perrone) reports the President "insisted Thursday that he is ready to resume campaign rallies and feels 'perfect,' but the White House has offered little i

L EMAIL] - FBI Public Affairs News Briefing Friday, October 23, 2020 To: [email protected] Sent: October 23, 2020 6:26 AM (UTC-04:00) Mobile version and searchable archives available at tbi.bulletinintellioence.com. TO : THE DIRECTOR AND SENIOR STAFF DATE : FRIDAY, OCTOBER 23, 20

e relatively low bar used this year for emergency use authorization for treatments." Calling the meeting "an usual step," the AE (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust and confi

ubject: [EXTERNAL EMAIL] - FBI Public Affairs 2020 Date: Fri, 23 Oct 2020 10:26:13 +0000 c Importan e: Normal News Briefing Friday, October 23, Mobile version and searchable archives available at fbi.bulletinintelligence.com. 'FBI News Briefing TO: THE DIRECTOR AND SENIOR STAFF DATE: FRIDAY, OCTOB

e relatively low bar used this year for emergency use authorization for treatments." Calling the meeting "an usual step," the AP (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust and confi

of Investigation Seal December 01, 2021 Federal Bureau of Investigation Daily News Briefing (In coordination with the Office of Public Affairs) Mobile version and searchable archives available at https://fbi.barbaricumanalytics.com Table of Contents IN THE NEWS • Authorities: Student Kills Three,

(11/30, Staff Writer) and The Epoch Times (11/30, Nguyen Ly). US Panel Backs First-Of-A-Kind COVID-19 Pill From Merck The Associated Press (11/30, Perrone) reported that a panel of Food and Drug Administration (FDA) health advisers voted 13-10 in support of Merck's new COVID-19 pill, molnupiravir, stat

Eastern Time (US & Canada) To: [email protected] Subject: [EXTERNAL EMAIL] - FBI Public Affairs News Briefing Friday, October 09, 2020 Mobile version and searchable archives available at fbi.bulletinintelligence.com. ;FBI News Briefing TO: THE DIRECTOR AND SENIOR STAFF DATE: FRIDAY, OCTOB

er, joined him in the Oval Office today, according to a senior White House official. All they say wearing full PPE." The AP (10/8, Madhani, Colvin, Perrone) reports the President "insisted Thursday that he is ready to resume campaign rallies and feels `perfect,' but the White House has offered little i

Eastern Time (US & Canada) To: [email protected] Subject: [EXTERNAL EMAIL] - FBI Public Affairs News Briefing Friday, November 20, 2020 Mobile version and searchable archives available at fbi.bulletinintelligence.com. FBI News Briefing TO: THE DIRECTOR AND SENIOR STAFF DATE: FRIDAY, NOVEMB

getting ill and prevent somebody from getting seriously ill - that's huge...by anybody's standard." Labs Warn Of COVID Test Delays. The AP (11/19, Perrone, Renault) reports that testing laboratories have "warned that continuing shortages of key supplies are likely to create more bottlenecks and delays"

tern Time (US & Canada) To: [email protected] Subject: [EXTERNAL EMAIL] - FBI Public Affairs News Briefing Thursday, September 03, 2020 Mobile version and searchable archives available at fbi.bulletinintelligence.com. WIBI News Briefing TO: THE DIRECTOR AND SENIOR STAFF DATE: THURSDAY, SEP

on his one true ally: Donald Trump." Another FDA Appointee Ousted Amid Fallout Over Convalescent Plasma Announcement. EFTA01658721 The AP (9/2, Perrone, Foley) reports, "A second Trump administration appointee has been ousted at the Food and Drug Administration in the wake of the agency's botched an